Efficacy, Safety, and Tolerability of HB0043 in Hidradenitis Suppurativa Patients.

Clinical trial NCT06895499 · RECRUITING

Trial details

NCT number: NCT06895499
Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hidradenitis Suppurativa

Start date: 2025-03-19
Primary completion: 2026-01-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.